Woodline Partners LP Trims Holdings in HealthEquity, Inc. (NASDAQ:HQY)

by · The Markets Daily

Woodline Partners LP decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 44.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 187,956 shares of the company’s stock after selling 148,827 shares during the period. Woodline Partners LP owned about 0.22% of HealthEquity worth $18,034,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of HQY. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity during the fourth quarter valued at $26,000. Transce3nd LLC acquired a new stake in HealthEquity in the fourth quarter worth about $29,000. Smartleaf Asset Management LLC lifted its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after purchasing an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new stake in HealthEquity in the fourth quarter valued at approximately $39,000. Finally, UMB Bank n.a. increased its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

HQY opened at $98.79 on Thursday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a fifty day moving average price of $88.09 and a 200 day moving average price of $97.24. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The stock has a market cap of $8.54 billion, a P/E ratio of 90.63, a P/E/G ratio of 1.60 and a beta of 0.45.

Analyst Ratings Changes

Several brokerages have commented on HQY. Barrington Research restated an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a research note on Friday, April 11th. The Goldman Sachs Group dropped their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a report on Thursday, March 27th. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their price objective for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. KeyCorp dropped their price objective on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Wednesday, April 16th. Finally, Wells Fargo & Company upped their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $111.75.

Check Out Our Latest Analysis on HQY

Insider Activity at HealthEquity

In related news, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. The trade was a 13.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now owns 84,969 shares of the company’s stock, valued at $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories